AG
SLS icon

Advisor Group’s SELLAS Life Sciences SLS Stock Holding History

Advisor Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
160
– – ﹤0.01% 5186
2019
Q3 		$1K Buy
160
+80
+100% +$589 ﹤0.01% 5160
2019
Q2 		$0 Buy
+80
New +$2.84K ﹤0.01% 5347
2019
Q1 		– Hold
0
– – – 5319
2018
Q4 		– Hold
0
– – – 5217
2018
Q3 		– Hold
0
– – – 5206
2018
Q2 		– Hold
0
– – – 5036
2018
Q1 		– Hold
0
– – – 5061
2017
Q4 		– Hold
0
– – – 5057
2017
Q3 		– Sell
-1
Closed -$660 – 4935
2017
Q2 		$0 Hold
1
– – ﹤0.01% 4897
2017
Q1 		$0 Hold
1
– – ﹤0.01% 4790
2016
Q4 		$1K Buy
+1
New +$5.82K ﹤0.01% 4391

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisor Group's SLS Position: Q4 2019 in Review

Advisor Group held its SELLAS Life Sciences (SLS) position steady in Q4 2019 at 160 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5186.

Advisor Group first reported a position in SLS in Q4 2016 and has held it in 6 quarters since. 11 funds tracked by Wall St. Rank hold SLS as of Q4 2019.

  • Advisor Group held 160 shares of SELLAS Life Sciences worth $1K as of Q4 2019.
  • Advisor Group left its SELLAS Life Sciences share count unchanged in Q4 2019.
  • SELLAS Life Sciences made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5186 holding.
  • Advisor Group first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 6 quarters since.
  • 11 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.